APA ציטוט

Hirsch, I. B., Bode, B., Courreges, J., Dykiel, P., Franek, E., Hermansen, K., . . . Davies, M. (2012). Insulin Degludec/Insulin Aspart Administered Once Daily at Any Meal, With Insulin Aspart at Other Meals Versus a Standard Basal-Bolus Regimen in Patients With Type 1 Diabetes: A 26-week, phase 3, randomized, open-label, treat-to-target trial. American Diabetes Association.

Citação norma Chicago

Hirsch, Irl B., Bruce Bode, Jean-Pierre Courreges, Patrik Dykiel, Edward Franek, Kjeld Hermansen, Allen King, Henriette Mersebach, and Melanie Davies. Insulin Degludec/Insulin Aspart Administered Once Daily At Any Meal, With Insulin Aspart At Other Meals Versus a Standard Basal-Bolus Regimen in Patients With Type 1 Diabetes: A 26-week, Phase 3, Randomized, Open-label, Treat-to-target Trial. American Diabetes Association, 2012.

ציטוט MLA

Hirsch, Irl B., et al. Insulin Degludec/Insulin Aspart Administered Once Daily At Any Meal, With Insulin Aspart At Other Meals Versus a Standard Basal-Bolus Regimen in Patients With Type 1 Diabetes: A 26-week, Phase 3, Randomized, Open-label, Treat-to-target Trial. American Diabetes Association, 2012.